Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Merck Interview Information > Merck Information > Flashcards

Merck Information Flashcards

(24 cards)

Start Studying
1
Q

Who is Merck’s Chairman of the Board, President, and Chief Executive Officer?

A

Kenneth C. Frazier:

  • One of the fewBlack CEOs running a large, publicly traded corporation in the U.S.
  • In September 2018 Merck’s board of directors revised the company’s retirement policy so that Frazier can remain in his current post as chairman and CEO after he turns 65 in 2020.
  • Has been with Merck since 1992.
  • Merck President since 2010.
  • Merck Chairman of the Board and CEO since 2011.
  • Holds a J.D. from Harvard Law School.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where is Merck Headquartered?

A

Kenilworth, N.J., U.S.A.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many countries does Merck operate in?

A

> 140 countries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How many employees does Merck have worldwide?

A

~ 69,000 employees worldwide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are Merck’s 4 Core Product Categories?

A
  1. Diabetes
  2. Cancer
  3. Vaccines
  4. Hospital Acute Care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are Merck’s 3 Business Categories?

A
  1. Pharmaceuticals
  2. Vaccines
  3. Animal Health
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What was Merck’s Total Revenue in 2017?

A

$40.1 Billion:

  • United States: $15.9 Billion
  • EU, Middle East, Africa: $9.8 Billion
  • Asian Pacific: $3.9 Billion
  • Japan: $3.0 Billion
  • Latin America: $1.8 Billion
  • Other: $1.0 Billion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What were Merck’s Top Selling Pharmaceutical Products 2015-2017?

A
  1. Januvia/Janumet
  2. Keytruda
  3. Gardasil/Gardasil 9
  4. Zetia/Vytorin
  5. ProQuad/MMR-II/Vartvax
  6. Zepatier
  7. Isentress/Isentress HD
  8. Remicaid
  9. Pneumovax 23
  10. Simponi
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What were Merck’s R&D expenses in 2017?

A

$7.3 Billion (excludes restructuring and merger-related expenses)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are Merck’s 7 Cardiovascular Drugs/Products?

A
  1. COZAAR® (losartan potassium) tablets, for oral use​
  2. HYZAAR® (losartan potassium and hydrochlorothiazide) tablets, for oral use​
  3. INTEGRILIN® (eptifibatide) Injection For Intravenous Administration​
  4. PRINIVIL® (lisinopril) tablets, for oral use​
  5. VYTORIN® (ezetimibe and simvastatin) Tablets​
  6. ZETIA® (ezetimibe) Tablets​
  7. ZOCOR® (simvastatin) Tablets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are Merck’s 9 Endocrinology Drugs/Products?

A
  1. FOSAMAX® (alendronate sodium) tablets and oral solution
  2. FOSAMAX® PLUS D (alendronate sodium/cholecalciferol) tablets
  3. JANUMET® (sitagliptin and metformin HCl) tablets
  4. JANUMET®XR (sitagliptin and metformin HCl extended-release) tablets
  5. JANUVIA® (sitagliptin) Tablets
  6. Pregnyl™ (chorionic gonadotropin for injection USP)
  7. SEGLUROMET™ (ertugliflozin and metformin) tablets, for oral use
  8. STEGLATRO™ (ertugliflozin) tablets, for oral use
  9. STEGLUJAN™ (ertugliflozin and sitagliptin) tablets, for oral use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are Merck’s 2 Immunology Drugs/Products?

A
  1. CELESTONE® SOLUSPAN® (betamethasone sodium phosphate and betamethasone acetate) Injectable Suspension, USP 30 mg/5 mL (6 mg/mL)
  2. RENFLEXIS™ (infliximab-abda) for injection, for intravenous use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are Merck’s 24 Infectious Disease Drugs/Products?

A
  1. CANCIDAS® (caspofungin acetate) for Injection, for intravenous use
  2. CRIXIVAN® (INDINAVIR SULFATE) CAPSULES
  3. CUBICIN® (daptomycin for injection) for Intravenous Use
  4. CUBICIN®RF (daptomycin for injection), for intravenous use
  5. DELSTRIGO™ (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use
  6. DIFICID® (fidaxomicin) tablets, for oral use
  7. INVANZ® (ertapenem for Injection) for intravenous (IV) or intramuscular (IM) use
  8. ISENTRESS® (raltegravir) film-coated tablets, for oral use
  9. ISENTRESS® HD (raltegravir) film-coated tablets, for oral use
  10. ISENTRESS® (raltegravir) chewable tablets, for oral use
  11. ISENTRESS® (raltegravir) for oral suspension
  12. Noxafil® (posaconazole) injection 18mg/mL, delayed-release tablets 100 mg, and oral suspension 40 mg/mL
  13. PEGINTRON® (peginterferon alfa-2b) injection, for Subcutaneous Use
  14. PIFELTRO™ (doravirine) tablets, for oral use
  15. PRIMAXIN® I.V. (imipenem and cilastatin) for Injection, for intravenous use
  16. PREVYMIS™ (letermovir) tablets, for oral use
  17. PREVYMIS™ (letermovir) injection, for intravenous use
  18. REBETOL® (ribavirin USP) Capsules, and Oral Solution
  19. SIVEXTRO® (tedizolid phosphate) for injection, for intravenous use
  20. SIVEXTRO® (tedizolid phosphate) tablet, for oral use
  21. STROMECTOL® (IVERMECTIN) TABLETS
  22. ZEPATIER® (elbasvir and grazoprevir) tablets, for oral use
  23. ZERBAXA™ (ceftolozane and tazobactam) for injection, for intravenous use
  24. ZINPLAVA™ (bezlotoxumab) injection, for intravenous use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are Merck’s 9 Neuroscience Drugs/Products?

A
  1. BELSOMRA® (suvorexant) tablets, for oral use, C-IV
  2. BRIDION® (sugammadex) Injection, for intravenous use
  3. GUANIDINE HYDROCHLORIDE Tablets
  4. MAXALT® (rizatriptan benzoate) tablets, for oral use
  5. MAXALT-MLT® (rizatriptan benzoate) orally disintegrating tablets
  6. REMERON® (mirtazapine) Tablets
  7. REMERONSolTab® (mirtazapine) Orally Disintegrating Tablets
  8. SINEMET® (carbidopa-levodopa) Tablets
  9. SINEMET® CR (carbidopa-levodopa) Sustained-Release Tablets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are Merck’s 11 Oncology Drugs/Products?

A
  1. EMEND® (aprepitant) capsules, (aprepitant) for oral suspension
  2. EMEND® (fosaprepitant) for injection, for intravenous use
  3. INTRON® A Interferon alfa-2b, recombinant For Injection
  4. KEYTRUDA® (pembrolizumab) for injection, for intravenous use
  5. KEYTRUDA® (pembrolizumab) injection, for intravenous use
  6. SYLATRON™ (peginterferon alfa-2b) for Injection, for subcutaneous use
  7. TEMODAR® Capsules (temozolomide)
  8. TEMODAR® for Injection (temozolomide)
  9. TICE® BCG
  10. BCG LIVE (FOR INTRAVESICAL USE)
  11. ZOLINZA® (vorinostat capsules, for oral use)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Merck’s 1 Ophthalmic Drug/Product?

Study These Flashcards
A

TRUSOPT® (dorzolamide hydrochloride ophthalmic solution), Sterile Ophthalmic Solution 2%

17
Q

What are Merck’s 8 Respiratory Drugs/Products?

Study These Flashcards
A
  1. ASMANEX® HFA (mometasone furoate) inhalation aerosol, for oral inhalation use
  2. ASMANEX® TWISTHALER® (mometasone furoate inhalation powder)
  3. CLARINEX® (desloratadine) Tablets and Oral Solution for oral use
  4. CLARINEX-D®12 HOUR Extended Release Tablets (desloratadine/pseudoephedrine sulfate) for oral use
  5. DULERA® (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol, for oral inhalation use
  6. NASONEX® (mometasone furoate monohydrate) Nasal Spray, 50 mcg†, †calculated on the anhydrous basis
  7. PROVENTIL®HFA (albuterol sulfate) Inhalation Aerosol
  8. SINGULAIR® (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules
18
Q

What is Merck’s 1 Urology Drug/Product?

Study These Flashcards
A

PROSCAR® (finasteride) Tablets

19
Q

What are Merck’s 5 Women’s Health Drugs/Products?

Study These Flashcards
A
  1. Follistim®AQ Cartridge (follitropin beta injection) for subcutaneous use
  2. Ganirelix Acetate Injection FOR SUBCUTANEOUS USE ONLY
  3. IMPLANON® (etonogestrel implant), for subdermal use
  4. NEXPLANON® (etonogestrel implant) Radiopaque Subdermal Use Only
  5. NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)
20
Q

What are Merck’s 11 Other Drugs/Products?

Study These Flashcards
A
  1. ANTIVENIN™ (LATRODECTUS MACTANS), (Black Widow Spider Antivenin)
  2. DIPROLENE®AF (augmented betamethasone dipropionate) Cream, 0.05% for topical use
  3. DIPROLENE® (augmented betamethasone dipropionate) Lotion, 0.05% for topical use
  4. DIPROLENE® (augmented betamethasone dipropionate) Ointment, 0.05% for topical use
  5. ELOCON® (mometasone furoate) Cream, 0.1% for topical use
  6. ELOCON® (mometasone furoate) Lotion, 0.1% for topical use
  7. ELOCON® (mometasone furoate) Ointment, 0.1% for topical use
  8. EMEND® (aprepitant) capsules, (aprepitant) for oral suspension
  9. ENTEREG® (alvimopan) capsules, for oral use
  10. LOTRISONE® Cream (clotrimazole and betamethasone dipropionate)
  11. PROPECIA® (finasteride) tablets for oral use
21
Q

Which former president of the Global Human Health (GHH) division, stepped down from his position on Dec. 31, 2018?

Study These Flashcards
A

Adam H. Schechter​

22
Q

How has Merck recently reshaped the commercial organization (which includes GHH)?

Study These Flashcards
A
  1. Adam H. Schechter stepped down from his position as President of Global Human Health (GHH) on December 31, 2018.
  2. Frank Clyburn (Most recently the President of the Global Oncology business) has been promoted to Chief Commercial Officer, effective January 1, 2019. In his new role, Clyburn will report directly to Ken Frazier and will be a member of the Executive Committee. He will be responsible for all operations and P&L across Merck’s human health commercial portfolio globally.
  3. Michael Nally (most recently led the company’s Vaccines business) has been promoted to Chief Marketing Officer, effective January 1, 2019. In his new role, Nally will report directly to Ken Frazier and will be a member of the Executive Committee. He will be responsible for Global Marketing and long-term franchise strategy across the portfolio.
23
Q

BOSS

Matthew Stafford information

Study These Flashcards
A
  • Job Title: Director, Health Care Systems, Mid-Central US Market
  • Job Description: Lead an Integrated Account Management team of 9 strategic account managers (SAMs) responsible for >$500M in annual net sales for Merck. SAMs are responsible for contracting, new business development and Population Health Management collaboration between Merck and the top Payers,IDNs, PBMs, and Hospital Systems based in MO, IA, CO, NE and KS. National lead for IDN segment strategy and execution; national lead for Vaccines.
  • Dates Employed in current position: Jan 2018 – Present (1 yr 1 mo)
  • Previous Position:
    • Job Title: IDS Market Leader, South Central Region
    • Dates Employed in current position: Jul 2014 – Dec 2017 (3 yrs 6 mos)
    • Job Description: Chosen as 1 of 6 Directors to build and launch a US market Integrated Delivery Systems (IDS) team of 65 IDS Account Directors (ADs) and Leaders (ALs) focused on the IDN segment. Partnered with US VP and leadership team to develop a segment strategy and customer segmentation model, new brand strategies and capabilities, as well as recruited and hired an entirely new team of IDS ADs/ALs to launch this new Organization for Merck. Team exceeded plan performance all 3 years and contributed >$50M in above plan, net-sales performance over that period. Merck Special Achievement Award recipient.
  • Been with Merck for ~29 years
  • Education:
    • B.A. Business/Corporate Communications - University of Kansas (he was a Strong Safety from 1988-1992; look up Jayhawk football stats)
    • M.B.A. - Webster University
    • Kellogg Executive Education program

Merck Interview Information (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions